3 hours Ionis Pharmaceuticals (NASDAQ:IONS) Given New $65.00 Price Target at Guggenheim MarketBeat
Guggenheim decreased their price objective on shares of Ionis Pharmaceuticals from $70.00 to $65.00 and set a “buy” rating for the company in a report on Wednesday.